Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sophie E. M. Kelly"'
Autor:
Eliza M. Gordon‐Lipkin, Christopher S. Marcum, Shannon Kruk, Elizabeth Thompson, Sophie E. M. Kelly, Heather Kalish, Lorenza Bellusci, Surender Khurana, Kaitlyn Sadtler, Peter J. McGuire
Publikováno v:
Clinical and Translational Medicine, Vol 12, Iss 11, Pp n/a-n/a (2022)
Abstract Background Viral infection is a major cause of morbidity in children with mitochondrial disease (MtD). As a result, families with children with MtD are highly adherent to risk mitigation behaviours (RMBs) advised by the Centers for Disease C
Externí odkaz:
https://doaj.org/article/f445df924f74444d862fd437e2858e7f
Autor:
Brian P Epling, Joseph M Rocco, Kristin L Boswell, Elizabeth Laidlaw, Frances Galindo, Anela Kellogg, Sanchita Das, Allison Roder, Elodie Ghedin, Allie Kreitman, Robin L Dewar, Sophie E M Kelly, Heather Kalish, Tauseef Rehman, Jeroen Highbarger, Adam Rupert, Gregory Kocher, Michael R Holbrook, Andrea Lisco, Maura Manion, Richard A Koup, Irini Sereti
Publikováno v:
Clinical Infectious Diseases. 76:573-581
Background Nirmatrelvir/ritonavir, the first severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) protease inhibitor, reduces the risk of hospitalization and death by coronavirus disease 2019 (COVID-19) but has been associated with symptomati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5048ffdbe16bdbdb0012f954d6ce766
https://doi.org/10.1093/cid/ciac663
https://doi.org/10.1093/cid/ciac663
Autor:
Brian P. Epling, Joseph M. Rocco, Kristin L. Boswell, Elizabeth Laidlaw, Frances Galindo, Anela Kellogg, Sanchita Das, Allison Roder, Elodie Ghedin, Allie Kreitman, Robin L. Dewar, Sophie E. M. Kelly, Heather Kalish, Tauseef Rehman, Jeroen Highbarger, Adam Rupert, Gregory Kocher, Michael R. Holbrook, Andrea Lisco, Maura Manion, Richard A. Koup, Irini Sereti
Publikováno v:
medRxiv : the preprint server for health sciences.
Clinical rebound of COVID-19 after nirmatrelvir/ritonavir treatment has been reported. We performed clinical, virologic, and immune measurements in seven patients with symptomatic rebound, six after nirmatrelvir/ritonavir treatment and one without pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::274ed9ce8bd7e9aae30862858c6cd222
https://pubmed.ncbi.nlm.nih.gov/36200701
https://pubmed.ncbi.nlm.nih.gov/36200701